A quick reminder, children have a 99.99% chance of surviving COVID-19 if they were to contract the virus.
So, why would we inject them with an experimental vaccine that has already caused thousands of deaths and hundreds of thousands of injuries?
Big Pharma’s fat pockets for one.
Pfizer is already expected to earn record profits from the COVID-19 vaccine alone.
The more people they can inject with their experimental jabs, the fatter their pockets become.
But as we’ve seen, the cure has shown to be worse than the disease for thousands of adult vaccine recipients.
— Robert F. Kennedy Jr (@RobertKennedyJr) May 1, 2021
However, they’re moving forward to put children on the list of those able to receive the experimental vaccine under emergency use authorization.
Pfizer’s jab was granted EUA in December for 16 years and older.
They’re now pushing for children ages 12-15 to be eligible for the two-dose jab.
10 Million Kids Could Get Pfizer COVID Vaccine by Fall • Children's Health Defense https://t.co/nAQR5XaGut
— Margaret Weston (@margweston) May 4, 2021
The FDA is expected to approve the Pfizer COVID-19 vaccine for teens ages 12-15 perhaps sooner than next week, maybe within a matter of days.
And approval for even younger children could come by fall. https://t.co/fX2N4vmbRO
— Jonathan Lemire (@JonLemire) May 3, 2021
If all goes well, the BioNTech-Pfizer vaccine for COVID-19 could be approved for ages 12 and older by June, and for kids above the age of six months by the fall. But the development would raise new moral and practical questions. https://t.co/pku4L0fm5B @derspiegel #COVID19 #utpol
— Mark Alvarez (@alvarezmark) May 1, 2021
Vaccine maker Pfizer has applied for Us FDA emergency use authorization for its coronavirus vaccine for teens & children ages 12 to 15.
This means we can get all middle school & high school students vaccinated before school starts in the fall. https://t.co/vl0LGfNyLR
— ProfHelen, PhD (@Helenhs) April 30, 2021
Wondering when your younger children could be able to get vaccinated? Pfizer COVID-19 vaccine for children ages 12-15 could be approved in May. Question: Would this make you feel safer sending them to in person learning this fall? https://t.co/d59cbuoQ9e #FOX35 #FOX35ORLANDO
— Danielle Knox FOX 35 (@Fox35Danielle) April 29, 2021
Here’s Scott Gottlieb, the former head of the FDA, discussing the experimental vaccines for children under age 16:
WATCH: Former FDA commissioner @ScottGottliebMD on impacts of a Pfizer vaccine being authorized for children:
"We'll pick up about 5 million immediately. I think probably another 5 million, 5-7 million would get vaccinated over the course of the summer before the school year." pic.twitter.com/Ua78ZQXP5b
— Face The Nation (@FaceTheNation) May 2, 2021
Fox News reported:
The former head of the U.S. Food and Drug Administration (FDA) said over the weekend that some 10 million U.S. children could receive the Pfizer-BioNTech coronavirus vaccine before fall should the jab receive emergency use authorization for the nation’s younger population.
During an appearance on CBS News’ “Face the Nation” Sunday, former FDA chief Dr. Scott Gottlieb estimated that some 5 million children between the ages of 12 and 15 would immediately receive the jab following approval, while another 5 to 7 million would likely be vaccinated before the beginning of the fall 2021 school year.
“Look, I’m hopeful that the FDA is going to authorize the Pfizer vaccine, the company I’m on the board of, [which] has applied for permission to start giving its vaccine to 12- to 15-year-olds,” Gottlieb said. “I’m hopeful the FDA is going to authorize that in a very short time period. And I think once that gets authorized, I think you’ll pick up probably 5 million kids [who] will get immediately vaccinated. There [are] about 17 million children between the age of 12 and 15. I think we’ll pick up about 5 million immediately. I think probably another 5 million, 5 [million] to 7 million, would get vaccinated over the course of the summer before the school year.”
“That’ll be incremental, Americans getting vaccinated against COVID and hopefully providing protection in an age group that has been susceptible to the infection. Older kids are more susceptible, certainly than younger kids,” he added, noting that pediatricians will likely be driving the vaccination effort in this group.
Gottlieb’s comments come after Pfizer in March announced that a Phase 3 trial involving its coronavirus vaccine in adolescents ages 12 to 15 was found to be safe and 100% effective. The BNT162b2 vaccine produced “robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old,” and that it was well tolerated, company officials said at the time.
The trial had enrolled 2,260 adolescents and saw 18 cases of COVID-19 among the placebo group, and none in the vaccinated group. Side effects were consistent with those seen in previous trials involving older participants ages 16 through 25. The participants will continue to be monitored for long-term protection and safety over the next two years.
Pfizer has since requested their emergency use authorization with the FDA to also be extended to children 12 to 15 years old. The two-dose vaccine was granted EUA in December for those 16 years of age and older.
For a virus that children virtually have zero risk, how much sense does it make to inject them with an experimental vaccine with so many unknowns?